Sharps Technology, Inc. (STSSW)

US — Financial Services Sector
Peers: STVN  STSS  TNON  SPRC  OKYO 

Automate Your Wheel Strategy on STSSW

With Tiblio's Option Bot, you can configure your own wheel strategy including STSSW - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol STSSW
  • Rev/Share 0.2155
  • Book/Share 14.6096
  • PB 1.0704
  • Debt/Equity 0.0
  • CurrentRatio 4.1806
  • ROIC -0.8642

 

  • MktCap 16001532.0
  • FreeCF/Share -9.8833
  • PFCF -1.6268
  • PE -21.5161
  • Debt/Assets 0.0
  • DivYield 0
  • ROE -0.0872

 

  • Rating C+
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 5
  • P/B Score 4
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

About Sharps Technology, Inc. (STSSW)

  • IPO Date 2022-04-14
  • Website https://sharpstechnology.com
  • Industry Financial - Capital Markets
  • CEO Robert M. Hayes
  • Employees 55
Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.